Citations 2

Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis

Amyloid | October 28, 2025 | Volume: 33 | Issue: 1 | Pages: 85-89

10.1080/13506129.2025.2577361 | PMID 41147681

Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial

Amyloid | November 18, 2024 | Volume: 32 | Issue: 1 | Pages: 29-38

10.1080/13506129.2024.2427290 | PMID 39552152